MedTrace Logo

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

NCT00561717 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-05-07

No results posted yet for this study

Summary

Finding out how fast azelastine nasal spray works in subjects with hay fever.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Azelastine and placebo

One Astelin spray per nostril plus one placebo tablet. In Cross-Over-Design with other arms.

DRUG

Loratadine and Placebo

One placebo spray per nostril plus one Loratadine 10 mg tablet. In Cross-Over-Design with other arms.

DRUG

Cetirizine and Placebo

One placebo spray per nostril plus one 10 mg Cetirizine tablet. In Cross-Over-Design with other arms.

DRUG

Placebo and Placebo (spray and Tablet)

One placebo spray per nostril plus one placebo tablet. In Cross-Over-Design with other arms.

Sponsors & Collaborators

  • Kingston Health Sciences Centre

    collaborator OTHER

  • Bayer

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-12-31
Completion
2008-02-29

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561717 on ClinicalTrials.gov